Optimising cardiovascular care of patients with multiple myeloma

CV events affect up to 7.5% of patients with multiple myeloma, due to combination of patient, disease and treatment-related factors and adversely impact survival. Review summarises current knowledge and provide practical considerations on management of CV complications.

Heart